Manage, Belgium

Flore Vandemeulebroucke

This inventor holds 2 USPTO granted patents and 7 published patent applications and 3 EPO patents. Top assignees: Dow Corning Corporation, Dow Silicones Corporation. Active years: 2014-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Flore Vandemeulebroucke: Innovator in Antimicrobial Technology

Introduction

Flore Vandemeulebroucke is a notable inventor based in Manage, Belgium. She has made significant contributions to the field of antimicrobial technology. Her innovative work has led to the development of a unique patent that addresses important health and safety concerns.

Latest Patents

Flore holds a patent for "Antimicrobial quaternary ammonium organosilane compositions." This invention involves antimicrobial granules that comprise carrier particles agglomerated by a binding agent containing a quaternary ammonium organosilane. This technology has the potential to enhance the effectiveness of antimicrobial applications in various industries.

Career Highlights

Flore Vandemeulebroucke is currently employed at Dow Corning Corporation, where she continues to push the boundaries of innovation in her field. Her work at this esteemed company has allowed her to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Nicoias Ziolkowski and Jean-Paul H Lecomte. Their collaborative efforts have further advanced the research and development of antimicrobial technologies.

Conclusion

Flore Vandemeulebroucke is a pioneering inventor whose work in antimicrobial technology is making a significant impact. Her patent and contributions to Dow Corning Corporation highlight her dedication to innovation and excellence in her field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…